Research & Innovation
We are the New England Phase I Center of the Children's Oncology Group. If your child has progressive or recurrent optic pathway gliomas, she may be eligible for a number of experimental therapies available through these groups, or from one of our independent clinical investigators.
What is the latest research on pleomorphic xanthoastrocytoma?
Children's Hospital and Dana-Farber Cancer Institute are conducting numerous research studies that will help clinicians better understand and treat pleomorphic xanthoastrocytoma. For more information on current research, see the Brain Tumor Program.